Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Breztri Aerosphere approved in U.S. for the maintenance treatment of COPD

July 27, 2020

Promising preclinical data for NurOwn-derived exosome-based therapy for COVID-19 ARDS

July 24, 2020

AdAlta begins treatment in phase I study of AD-214 for interstitial lung disease

July 23, 2020

FibroGenesis' PneumoBlast induces reduction of lung fibrosis

July 23, 2020

Chinese investigators patent P2X3 receptor antagonists

July 23, 2020

Phase III study of Trikafta in cystic fibrosis meets primary and secondary endpoints

July 21, 2020

FDA reviews pre-IND application for Tetra's ARDS-003 to prevent COVID-19-related ARDS

July 20, 2020

Single-cell studies give insights into pulmonary fibrosis

July 16, 2020

Vadadustat begins study to prevent and treat ARDS in patients with COVID-19

July 15, 2020

Novartis patents mutant CFTR correctors

July 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...